A Frank Assessment of SHANK : Impacts of Pathogenic Variations in SHANK3 on Preclinical Models of Phelan McDermid Syndrome
Autism Research · 2025-10 · 18 (10) · 1935-1964
DOI: 10.1002/aur.70112 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Autism Research, online erschienen am 28.08.2025. Verfasst von Vic Lin und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Health and Biomedical Sciences, RMIT University, Bundoora, Victoria, Australia. Hauptthemen laut MEDLINE: Nerve Tissue Proteins, Chromosome Disorders, Microfilament Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Axial Therapeutics.
Abstract (Originalsprache)
Although there are as many as 40 preclinical models of the neurodevelopmental disorder Phelan McDermid syndrome (PMS, or 22q13.3 deletion syndrome), detailed phenotypic analyses to compare the effects of different pathogenic variants and inform treatment design are lacking. Here, we clarify behavioral traits (social, vocalization, repetitive and anxiety‐like behavior), developmental trajectories, and motor activity in addition to changes in brain structure and function in 10 widely available Shank3 transgenic mouse models. Although behavioral deficits in Shank3B −/− and Shank3 ∆C/∆C mice were most extensively reported, each model reviewed here displayed autism‐relevant behavioral traits. Most studies focused on assessing social, anxiety‐like, and repetitive behavior, whereas few studies examined changes in vocalization, developmental milestones, motor function, or aggressive behavior. We did not identify any studies of gut function in the ten selected Shank3 models. Alterations in the gastrointestinal microbiome of Shank3‐deficient mice are associated with changes in bacterial abundance and composition, which may impact social behavior and gastrointestinal function. Studying preclinical models can provide critical insights into molecular pathways contributing to PMS. Further research is needed to determine how various genetic variations in Shank3 impact the brain, behavior, and potentially the gastrointestinal system.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Health and Biomedical Sciences, RMIT University, Bundoora, Victoria, Australia.
- Department of Biology, University of Miami, Coral Gables, Florida, USA.
- Department of Biomedical Engineering, The University of Melbourne, Parkville, Victoria, Australia.
- Human Genetics and Cognitive Functions, Institut Pasteur, UMR3571 CNRS, IUF, Université Paris Cité, Paris, France.
- Department of Microbiology, Anatomy and Physiology and Pharmacology, La Trobe University, Bundoora, Victoria, Australia.
- Department of Anatomy and Physiology, The University of Melbourne, Parkville, Victoria, Australia.
ORCID-Profile: Vic Lin
Förderung
- Axial Therapeutics
Zitieren
APA
Lin, V., Matta, S. M., Dallman, J. E., Hosie, S., Moreau, M., Franks, A. E., Bourgeron, T., & Hill-Yardin, E. L. (2025). A Frank Assessment of SHANK : Impacts of Pathogenic Variations in SHANK3 on Preclinical Models of Phelan McDermid Syndrome. Autism Research, 18(10), 1935-1964. https://doi.org/10.1002/aur.70112
Vancouver
Lin V, Matta SM, Dallman JE, Hosie S, Moreau M, Franks AE, et al. A Frank Assessment of SHANK : Impacts of Pathogenic Variations in SHANK3 on Preclinical Models of Phelan McDermid Syndrome. Autism Research. 2025;18(10):1935-1964. doi:10.1002/aur.70112
BibTeX
@article{Lin2025,
author = {Lin, Vic and Matta, Samantha M and Dallman, Julia E and Hosie, Suzanne and Moreau, Manon and Franks, Ashley E and Bourgeron, Thomas and Hill-Yardin, Elisa L},
title = {A Frank Assessment of SHANK : Impacts of Pathogenic Variations in SHANK3 on Preclinical Models of Phelan McDermid Syndrome},
journal = {Autism Research},
year = {2025},
volume = {18},
number = {10},
pages = {1935--1964},
doi = {10.1002/aur.70112}
}
EUVIMED